Carlsmed
CARL
57 hedge funds and large institutions have $57.7M invested in Carlsmed in 2025 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 7 closing their positions.
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
19% more funds holding
Funds holding: 48 → 57 (+9)
0.04% more ownership
Funds ownership: 17.53% → 17.58% (+0.04%)
8% less capital invested
Capital invested by funds: $62.4M → $57.7M (-$4.68M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.77M |
| 2 |
Millennium Management
New York
|
+$1.44M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$640K |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$635K |
| 5 |
BlackRock
New York
|
+$560K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$4.31M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.47M |
| 3 |
ZP
Zimmer Partners
New York
|
-$670K |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$536K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$411K |
CARL Hedge Fund Activity: Q4 2025 in Review
57 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in Carlsmed (CARL) for Q4 2025, worth a combined $57.7M — down 7.5% from $62.4M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new CARL positions and 7 closed out — a net gain of 9 holders — while 20 added to existing stakes and 9 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.77M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $4.31M sold.
- 57 institutional investors held Carlsmed (CARL) as of Q4 2025, up from 48 in Q3 2025.
- Funds reported $57.7M of Carlsmed stock for Q4 2025, down 7.5% quarter-over-quarter.
- 16 funds opened new Carlsmed positions in Q4 2025 and 7 closed out, a net change of +9 holders.
- The largest Carlsmed buyer in Q4 2025 was Vanguard Group, an estimated $1.77M added.
- The largest Carlsmed seller in Q4 2025 was Avidity Partners Management, an estimated $4.31M sold.
Based on aggregated 13F filings for Q4 2025.